Juxtapid

Amryt Pharmaceuticals DAC🇺🇸 United States

FDA Page

Effective Date: Apr 28, 2022
Approval ID: e4c45bb5-15f4-437e-ab98-a649b3676d14
Products: 4 registered
Version: 22

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use JUXTAPID safely and effectively. See full prescribing information for JUXTAPID. JUXTAPID (lomitapide) capsules, for oral use Initial U.S. Approval: 2012

Quick Stats

Total Products4

Labelers2

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.